SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-251144
Filing Date
2023-10-05
Accepted
2023-10-05 09:07:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d537538ddefa14a.htm DEFA14A 896135
2 GRAPHIC g537538g1005123038203.jpg GRAPHIC 3892
3 GRAPHIC g537538g1005123038436.jpg GRAPHIC 3903
  Complete submission text file 0001193125-23-251144.txt   908281
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38722 | Film No.: 231309923
SIC: 2836 Biological Products, (No Diagnostic Substances)